These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663 [TBL] [Abstract][Full Text] [Related]
3. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. Chang SP; Gibson HL; Lee-Ng CT; Barr PJ; Hui GS J Immunol; 1992 Jul; 149(2):548-55. PubMed ID: 1624802 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody characterization of the 195-kilodalton major surface glycoprotein of Plasmodium falciparum malaria schizonts and merozoites: identification of additional processed products and a serotype-restricted repetitive epitope. Lyon JA; Haynes JD; Diggs CL; Chulay JD; Haidaris CG; Pratt-Rossiter J J Immunol; 1987 Feb; 138(3):895-901. PubMed ID: 2433334 [TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface. Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864 [TBL] [Abstract][Full Text] [Related]
6. Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites. Okitsu SL; Boato F; Mueller MS; Li DB; Vogel D; Westerfeld N; Zurbriggen R; Robinson JA; Pluschke G Peptides; 2007 Oct; 28(10):2051-60. PubMed ID: 17875342 [TBL] [Abstract][Full Text] [Related]
7. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. Quakyi IA; Carter R; Rener J; Kumar N; Good MF; Miller LH J Immunol; 1987 Dec; 139(12):4213-7. PubMed ID: 2447164 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae. Hui GS; Gosnell WL; Case SE; Hashiro C; Nikaido C; Hashimoto A; Kaslow DC J Immunol; 1994 Sep; 153(6):2544-53. PubMed ID: 8077664 [TBL] [Abstract][Full Text] [Related]
9. A protective merozoite protein of Plasmodium falciparum shares an epitope with surface antigens of Paramecium. Sehgal A; Singh NJ; Chakraborty T; Sharma S Parasite Immunol; 2004 May; 26(5):219-27. PubMed ID: 15491471 [TBL] [Abstract][Full Text] [Related]
10. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum. Xu L; Pei X; Berzins K; Chaudhuri A Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297 [TBL] [Abstract][Full Text] [Related]
11. [Antigenic diversity of asexual schizont antigen GP195 of Plasmodium falciparum isolates from China]. Miao WM; Guan WB; Pang WQ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(2):110-3. PubMed ID: 1714800 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a Plasmodium falciparum epitope recognized by a monoclonal antibody with broad isolate and species specificity. Limpaiboon T; Taylor DW; Jones G; Geysen HM; Saul A Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):388-96. PubMed ID: 1706114 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles. Lalitha PV; Biswas S; Pillai CR; Saxena RK Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786 [TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25. Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417 [TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs. Roeffen W; Beckers PJ; Teelen K; Lensen T; Sauerwein RW; Meuwissen JH; Eling W Exp Parasitol; 1995 Feb; 80(1):15-26. PubMed ID: 7529717 [TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen. Roeffen W; Teelen K; van As J; vd Vegte-Bolmer M; Eling W; Sauerwein R Exp Parasitol; 2001 Jan; 97(1):45-9. PubMed ID: 11207113 [No Abstract] [Full Text] [Related]
17. Novel monoclonal antibody against truncated C terminal region of Histidine Rich Protein2 (PfHRP2) and its utility for the specific diagnosis of malaria caused by Plasmodium falciparum. Verma R; Jayaprakash NS; Vijayalakshmi MA; Venkataraman K Exp Parasitol; 2015 Mar; 150():56-66. PubMed ID: 25592728 [TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum: analysis of the cytoadherence inhibition of the human monoclonal antibody 33G2 and of antibodies reactive with antigen Pf332. Iqbal J; Perlmann P; Berzins K Exp Parasitol; 1993 Aug; 77(1):79-87. PubMed ID: 8344409 [TBL] [Abstract][Full Text] [Related]
20. Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies. Sam-Yellowe TY; Del Rio RA; Fujioka H; Aikawa M; Yang JC; Yakubu Z Exp Parasitol; 1998 Jul; 89(3):271-84. PubMed ID: 9676705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]